Lexaria Bioscience LEXX
NASDAQ LEXX
$3.19 +0.06 (+1.94%)
As of: Sep 30, 2026 · 9:47 AM EDT

Lexaria Bioscience (LEXX) Non-Current Debt (2011 - 2020)

Updated

Lexaria Bioscience (LEXX) posted Non-Current Debt of -$50,000 for FY2017 (year ended Aug 31, 2017), compared with $95,000 in FY2016.

Analysis

Lexaria Bioscience (LEXX) Non-Current Debt (2011 - 2020) Analysis & Trends

Since FY2010, Lexaria Bioscience has reported Non-Current Debt for 7 fiscal years.

  • Annual Non-Current Debt has run from a low of -$365,359 in FY2013 to a high of $95,000 in FY2016 over five years.
  • Business Quant data shows LEXX's Non-Current Debt at $95,000 in FY2016, -$98,742 in FY2015, -$306,893 in FY2014 and -$365,359 in FY2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Lexaria Bioscience 3.39 Mn -12.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2020 30,852.00
Aug 31, 2020 30,670.00
May 31, 2020 28,756.00
Oct 31, 2011 599,438.00
API Access

Lexaria Bioscience Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=LEXX&period=max&api_key=YOUR_API_KEY